Israel Biotech Fund I L.P. 13D and 13G filings for Ayala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 11:58 am Sale | 2024-02-05 | 13D | ADVAXIS INC PAR $0.001 ADXS | Israel Biotech Fund I L.P. | 45,792,542 71.630% | -4,947,327 (-9.75%) | Filing |
| 2023-11-21 09:00 am Purchase | 2023-11-17 | 13D | ADVAXIS INC PAR $0.001 ADXS | Israel Biotech Fund I L.P. | 50,739,869 83.600% | 47,060,869 (+1279.18%) | Filing |
| 2023-10-31 07:05 am Purchase | 2023-10-18 | 13D | ADVAXIS INC PAR $0.001 ADXS | Israel Biotech Fund I L.P. | 3,679,000 28.000% | 1,318,616 (+55.86%) | Filing |
| 2023-09-11 12:38 pm Purchase | 2023-09-01 | 13D | ADVAXIS INC PAR $0.001 ADXS | Israel Biotech Fund I L.P. | 2,360,384 35.900% | 2,360,384 (New Position) | Filing |